title: Results with living-donor kidney transplants from spouses: fourteen years of experience at our center.
authors.affiliation: Department of General Surgery and Transplantation Center, Başkent University Faculty of Medicine, Ankara, Turkey. melekk@baskent-ank.edu.tr
authors.forename: M
authors.initials: M
authors.lastname: Haberal
authors.forename: R
authors.initials: R
authors.lastname: Emiroglu
authors.forename: M C
authors.initials: MC
authors.lastname: Yagmurdur
authors.forename: H
authors.initials: H
authors.lastname: Karakayali
authors.forename: G
authors.initials: G
authors.lastname: Moray
authors.forename: G
authors.initials: G
authors.lastname: Arslan
authors.forename: N
authors.initials: N
authors.lastname: Bilgin
mesh_terms: D000328:Adult; D001787:Blood Group Incompatibility; D001803:Blood Transfusion; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000628:therapy; D006085:Graft Survival / Q000502:physiology*; D006650:Histocompatibility Testing; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D016030:Kidney Transplantation / Q000276:immunology / Q000401:mortality / Q000706:statistics & numerical data*; D019520:Living Donors; D008297:Male; D008875:Middle Aged; D016853:Muromonab-CD3; D010956:Plasmapheresis; D012189:Retrospective Studies; D016038:Skin Transplantation / Q000276:immunology; D018454:Spouses; D016019:Survival Analysis; D013997:Time Factors
chemical_list: D016853:Muromonab-CD3